Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Trinity Biotech PLC (NASDAQ:TRIB)

5.41
Delayed Data
As of 3:59pm ET
 -0.07 / -1.28%
Today’s Change
5.20
Today|||52-Week Range
13.68
-21.82%
Year-to-Date
No recent news for Trinity Biotech PLC.

Today’s Trading

Previous close5.48
Today’s open5.46
Day’s range5.32 - 5.63
Volume26,316
Average volume (3 months)61,257
Market cap$127.2M
Dividend yield4.07%
Data as of 3:59pm ET, 05/25/2017

Growth & Valuation

Earnings growth (last year)-559.49%
Earnings growth (this year)-9.23%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-0.33%
P/E ratioNM
Price/Sales1.97
Price/Book1.12

Competitors

 Today’s
change
Today’s
% change
VRMLVermillion Inc+0.08+4.65%
GALTGalectin Therapeutic...+0.01+0.43%
CGIXCancer Genetics Inc0.000.00%
TRILTrillium Therapeutic...-0.15-2.68%
Data as of 3:59pm ET, 05/25/2017

Financials

Next reporting dateAugust 1, 2017
EPS forecast (this quarter)$0.05
Annual revenue (last year)$99.3M
Annual profit (last year)-$100.3M
Net profit margin-38.73%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Ronan O'Caoimh
CFO, Secretary &
Head-Investor Relations
Kevin Tansley
Corporate headquarters
Bray, Wicklow

Forecasts